Abstract
Electroconvulsive therapy (ECT) procedures have risks, and these risks are associated with general anesthesia, tonic-clonic seizure and convulsion, the interaction between concomitant medications and ECT, and other procedural aspects of ECT. Based on the findings of a recent paper, ECT may be safer than is widely reported. The reported adverse events were mostly rare and generally minor in severity. According to the American Psychiatric Association, ECT has no absolute contraindications; however, some conditions pose a relatively high risk, and there are many other kinds of complications associated with ECT, with the cause of death during ECT essentially being from cardiovascular disorder. Understanding such complications and their management strategies avoids unnecessary discontinuation of treatment due to manageable ECT complications, and furthermore, ECT clinicians must also consider the risk-benefit ratio when treating high-risk and medically complicated patients. Moreover, anesthesiologists must evaluate risk factors carefully prior to ECT and pay attention to modifications in patient management or ECT technique that may diminish the level of risk. To avoid complications, it is very important that the anesthesiologist perform a pre-ECT evaluation. Proper anesthetic care also allows safe administration of ECT in patients with multiple coexisting medical conditions and even in very elderly patients.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Mankad MV, Weiner RD. Adverse effects. In: Mankad MV, Beyer JL, Weiner RD, Krystal AD, editors. Clinical manual of electroconvulsive therapy. Arlington: American Psychiatric Publishing, Inc.; 2010. p. 139–48.
Abrams R. The mortality rate with ECT. Convuls Ther. 1997;13:125–7.
Consoli A, De Carvalho W, Cohen D. Side effect of ECT. In: Ghaziuddin N, Walter G, editors. Electroconvulsive therapy in children and adolescents. New York: Oxford University Press; 2013. p. 140–60.
Watts BV, Groft A, Bagian JP, Mills PD. An examination of mortality and other adverse events related to electroconvulsive therapy using a national adverse event report system. J ECT. 2011;27:105–8.
Shiwach RS, Reid WH, Carmody TJ. An analysis of reported deaths following electroconvulsive therapy in Texas, 1993–1998. Psychiatr Serv. 2001;52:1095–7.
Nuttall GA, Bowersox MR, Douglass SB, McDonald J, Rasmussen LJ, Decker PA, Oliver Jr WC, Rasmussen KG. Morbidity and mortality in the use of electroconvulsive therapy. J ECT. 2004;20:237–41.
American Psychiatric Association. The practice of electroconvulsive therapy: recommendations for treatment, training, and priveleging, A task force report of the American Psychiatric Association. 2nd ed. Washington, DC: American Psychiatric Association; 2001.
Tomac TA, Rummans TA, Pileggi TS, Li H. Safety and efficacy of electroconvulsive therapy in patients over age 85. Am J Geriatr Psychiatry. 1997;5:126–30.
Stensrud PE. Anesthesia at remote locations. In: Miller RD, editor. Miller’s anesthesia, vol. 2. 7th ed. Philadelphia: Churchill Livingstone Elsevier; 2010. p. 2477–9.
Boere E, Birkenhager TK, Groenland TH, van den Broek WW. Beta-blocking agents during electroconvulsive therapy: a review. Br J Anaesth. 2014;113:43–51.
Cristancho MA, Alici Y, Augoustides JG, O'Reardon JP. Uncommon but serious complications associated with electroconvulsive therapy: recognition and management for the clinician. Curr Psychiatry Rep. 2008;10:474–80.
Bhat SK, Acosta D, Swartz CM. Postictal asystole during ECT. J ECT. 2002;18:103–6.
Robinson M, Lighthall G. Asystole during successive electroconvulsive therapy sessions: a report of two cases. J Clin Anesth. 2004;16:210–3.
Welch CA. Medical evaluation before electroconvulsive therapy. N Engl J Med. 2009;360:2791–2; author reply 2.
Bryson EO, Kellner CH, Ahle GM, Liebman LS. Asystole during electroconvulsive therapy. J ECT. 2014;30:259–60.
McCully RB, Karon BL, Rummans TA, Black JL, Andreen KM, Oh JK, Seward JB, Tajik AJ. Frequency of left ventricular dysfunction after electroconvulsive therapy. Am J Cardiol. 2003;91:1147–50.
Hase K, Yoshioka H, Nakamura T, Kamei T, Isse K, Nakamura M. Asystole during electroconvulsive therapy. Masui. 2005;54:1268–72.
Wajima Z, Yoshikawa T, Ogura A, Imanaga K, Shiga T, Inoue T, Ogawa R. The effects of diltiazem on hemodynamics and seizure duration during electroconvulsive therapy. Anesth Analg. 2001;92:1327–30.
Wajima Z, Yoshikawa T, Ogura A, Imanaga K, Shiga T, Inoue T, Ogawa R. Intravenous verapamil blunts hyperdynamic responses during electroconvulsive therapy without altering seizure activity. Anesth Analg. 2002;95:400–2, table of contents. Erratum in: Anesth Analg 2002;95:797.
Wajima Z, Shiga T, Yoshikawa T, Ogura A, Inoue T, Ogawa R. Propofol alone, sevoflurane alone, and combined propofol-sevoflurane anaesthesia in electroconvulsive therapy. Anaesth Intensive Care. 2003;31:396–400.
Wajima Z, Shiga T, Imanaga K, Inoue T. Prophylactic continuous administration of landiolol, a novel β1 blocker, blunts hyperdynamic responses during electroconvulsive therapy without altering seizure activity. Int J Psychiatry Clin Pract. 2010;14:132–6.
Simpson KH, Lynch L. Anaesthesia and electroconvulsive therapy (ECT). Anaesthesia. 1998;53:615–7.
Ding Z, White PF. Anesthesia for electroconvulsive therapy. Anesth Analg. 2002;94:1351–64.
Alpak G, Ercan S, Alici H, Bulbul F, Altunbas G, Alici D, Saricicek V, Davutoglu V. Influence of recurrent electroconvulsive therapy on cardiac function. Med Princ Pract. 2014;23:225–8.
Rice EH, Sombrotto LB, Markowitz JC, Leon AC. Cardiovascular morbidity in high-risk patients during ECT. Am J Psychiatry. 1994;151:1637–41.
Wagner KJ, Möllenberg O, Rentrop M, Werner C, Kochs EF. Guide to anaesthetic selection for electroconvulsive therapy. CNS Drugs. 2005;19:745–58.
Lee JT, Erbguth PH, Stevens WC, Sack RL. Modification of electroconvulsive therapy induced hypertension with nitroglycerin ointment. Anesthesiology. 1985;62:793–6.
Parab AL, Chaudhari LS, Apte J. Use of nitroglycerin ointment to prevent hypertensive response during electroconvulsive therapy–a study of 50 cases. J Postgrad Med. 1992;38:55–7.
Ciraulo D, Lind L, Salzman C, Pilon R, Elkins R. Sodium nitroprusside treatment of ECT-induced blood pressure elevations. Am J Psychiatry. 1978;135:1105–6.
Fu W, Stool LA, White PF, Husain MM. Is oral clonidine effective in modifying the acute hemodynamic response during electroconvulsive therapy? Anesth Analg. 1998;86:1127–30.
Akcaboy ZN, Akcaboy EY, Yigitbasl B, Bayam G, Dikmen B, Gogus N, Dilbaz N. Effects of remifentanil and alfentanil on seizure duration, stimulus amplitudes and recovery parameters during ECT. Acta Anaesthesiol Scand. 2005;49:1068–71.
Chen ST. Remifentanil: a review of its use in electroconvulsive therapy. J ECT. 2011;27:323–7.
Wells DG, Davies GG, Rosewarne F. Attenuation of electroconvulsive therapy induced hypertension with sublingual nifedipine. Anaesth Intensive Care. 1989;17:31–3.
Kalayam B, Alexopoulos GS. Nifedipene in the treatment of blood pressure rise after ECT. Convuls Ther. 1989;5:110–3.
Figiel GS, DeLeo B, Zorumski CF, Baker K, Goewert A, Jarvis M, Smith DS, Mattingly G, Ruwitch J. Combined use of labetalol and nifedipine in controlling the cardiovascular response from ECT. J Geriatr Psychiatry Neurol. 1993;6:20–4.
Avramov MN, Stool LA, White PF, Husain MM. Effects of nicardipine and labetalol on the acute hemodynamic response to electroconvulsive therapy. J Clin Anesth. 1998;10:394–400.
Kovac AL, Goto H, Arakawa K, Pardo MP. Esmolol bolus and infusion attenuates increases in blood pressure and heart rate during electroconvulsive therapy. Can J Anaesth. 1990;37:58–62.
Howie MB, Black HA, Zvara D, McSweeney TD, Martin DJ, Coffman JA. Esmolol reduces autonomic hypersensitivity and length of seizures induced by electroconvulsive therapy. Anesth Analg. 1990;71:384–8.
Kovac AL, Goto H, Pardo MP, Arakawa K. Comparison of two esmolol bolus doses on the haemodynamic response and seizure duration during electroconvulsive therapy. Can J Anaesth. 1991;38:204–9.
Weinger MB, Partridge BL, Hauger R, Mirow A. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: I. Effectiveness of pretreatment regimens on hemodynamics. Anesth Analg. 1991;73:556–62.
Howie MB, Hiestand DC, Zvara DA, Kim PY, McSweeney TD, Coffman JA. Defining the dose range for esmolol used in electroconvulsive therapy hemodynamic attenuation. Anesth Analg. 1992;75:805–10.
Castelli I, Steiner LA, Kaufmann MA, Alfille PH, Schouten R, Welch CA, Drop LJ. Comparative effects of esmolol and labetalol to attenuate hyperdynamic states after electroconvulsive therapy. Anesth Analg. 1995;80:557–61.
van den Broek WW, Leentjens AF, Mulder PG, Kusuma A, Bruijn JA. Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a double-blind, placebo-controlled study. Br J Anaesth. 1999;83:271–4.
Foster S, Ries R. Delayed hypertension with electroconvulsive therapy. J Nerv Ment Dis. 1988;176:374–6.
Stoudemire A, Knos G, Gladson M, Markwalter H, Sung YF, Morris R, Cooper R. Labetalol in the control of cardiovascular responses to electroconvulsive therapy in high-risk depressed medical patients. J Clin Psychiatry. 1990;51:508–12.
McCall WV, Shelp FE, Weiner RD, Austin S, Harrill A. Effects of labetalol on hemodynamics and seizure duration during ECT. Convuls Ther. 1991;7:5–14.
American Psychiatric Association, editor. The practice of electroconvulsive therapy: recommendations for treatment, training, and priveleging, A task force report of the American Psychiatric Association. 2nd ed. Washington, DC: American Psychiatric Association; 2001. p. 136.
Tess AV, Smetana GW. Medical evaluation of patients undergoing electroconvulsive therapy. N Engl J Med. 2009;360:1437–44.
Malik MO. Fatal heart block and cardiac arrest following ECT. A case report. Br J Psychiatry. 1972;120:69–70.
McCall WV. Asystole in electroconvulsive therapy: report of four cases. J Clin Psychiatry. 1996;57:199–203.
Russ MJ, Bailine SH. Asystole and bradycardia related to anesthetic induction during ECT: a case report. J ECT. 2004;20:195–7.
Birkenhäger TK, Pluijms EM, Groenland TH, van den Broek WW. Severe bradycardia after anesthesia before electroconvulsive therapy. J ECT. 2010;26:53–4.
Dec Jr GW, Stern TA, Welch C. The effects of electroconvulsive therapy on serial electrocardiograms and serum cardiac enzyme values. A prospective study of depressed hospitalized inpatients. JAMA. 1985;253:2525–9.
Cockey GH, Conti CR. Electroconvulsive therapy-induced transient T-wave inversions on ECG. Clin Cardiol. 1995;18:418–20.
Ali PB, Tidmarsh MD. Cardiac rupture during electroconvulsive therapy. Anaesthesia. 1997;52:884–6.
Lopez-Gomez D, Sanchez-Corral MA, Cobo JV, Jara F, Esplugas E. Myocardial infarction after electroconvulsive therapy. Rev Esp Cardiol. 1999;52:536.
Messina AG, Paranicas M, Katz B, Markowitz J, Yao FS, Devereux RB. Effect of electroconvulsive therapy on the electrocardiogram and echocardiogram. Anesth Analg. 1992;75:511–4.
Go O, Mukherjee R, Bhatta L, Carhart Jr R, Villarreal D. Myocardial stunning after electroconvulsive therapy in patients with an apparently normal heart. J ECT. 2009;25:117–20.
Satterthwaite TD, Cristancho MA, Alici Y, Weiss D, O'Reardon JP. Electroconvulsive therapy in a 72-year-old woman with a history of Takotsubo cardiomyopathy: a case report and review of the literature. Brain Stimul. 2009;2:238–40.
Beach SR, Wichman CL, Canterbury RJ. Takotsubo cardiomyopathy after electroconvulsive therapy. Psychosomatics. 2010;51:432–6.
Celano CM, Torri A, Seiner S. Takotsubo cardiomyopathy after electroconvulsive therapy: a case report and review. J ECT. 2011;27:221–3.
Narayanan A, Russell MD, Sundararaman S, Shankar KK, Artman B. Takotsubo cardiomyopathy following electroconvulsive therapy: an increasingly recognised phenomenon. BMJ Case Rep. 2014;2014.
Sharkey SW, Lesser JR, Zenovich AG, Maron MS, Lindberg J, Longe TF, Maron BJ. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation. 2005;111:472–9.
Kokras N, Politis AM, Zervas IM, Pappa D, Markatou M, Katirtzoglou E, Papadimitriou GN. Cardiac rhythm management devices and electroconvulsive therapy: a critical review apropos of a depressed patient with a pacemaker. J ECT. 2011;27:214–20.
Gosselink MJ, Schenkeveld KW, Trines SA, van Vliet IM. Successful electroconvulsive therapy in a 95-year-old man with a cardiac pacemaker–a case report. Am J Geriatr Psychiatry. 2011;19:678–9.
Dolenc TJ, Barnes RD, Hayes DL, Rasmussen KG. Electroconvulsive therapy in patients with cardiac pacemakers and implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2004;27:1257–63.
Zavorotnyy M, Zwanzger P. Prolonged apnea during electroconvulsive therapy in monozygotic twins: case reports. Ann Gen Psychiatry. 2011;10:30.
Naguib M, Lien CA. Pharmacology of muscle relaxant and their antagonists. In: Miller RD, editor. Miller’s anesthesia, vol. 1. 7th ed. Philadelphia: Churchill Livingstone Elsevier; 2010. p. 859–911.
Packman PM, Meyer DA, Verdun RM. Hazards of succinylcholine administration during electrotherapy. Arch Gen Psychiatry. 1978;35:1137–41.
De Hert M, Einfinger G, Scherpenberg E, Wampers M, Peuskens J. The prevention of deep venous thrombosis in physically restrained patients with schizophrenia. Int J Clin Pract. 2010;64:1109–15.
Medda P, Fornaro M, Fratta S, Callari A, Manzo V, Ciaponi B, Perugi G. A case of deep venous thrombosis following protracted catatonic immobility recovered with electroconvulsive therapy: the relevance for an early intervention. Gen Hosp Psychiatry. 2012;34:209.e5–7.
Clinebell K, Azzam PN, Gopalan P, Haskett R. Guidelines for preventing common medical complications of catatonia: case report and literature review. J Clin Psychiatry. 2014;75:644–51.
Weber DL, Ruvolo C, Cashin P. Sudden death following electroconvulsive therapy. N Y State J Med. 1973;73:1000–1.
Mamah D, Lammle M, Isenberg KE. Pulmonary embolism after ECT. J ECT. 2005;21:39–40.
Suzuki K, Takamatsu K, Takano T, Tanabe Y, Fujiyama K, Matsuoka H. Safety of electroconvulsive therapy in psychiatric patients shortly after the occurrence of pulmonary embolism. J ECT. 2008;24:286–8.
Singh G, Wahi S. Pulmonary embolism in the ECT patient: a case report and discussion. Gen Hosp Psychiatry. 2008;30:87–9.
Kalava A, Kalstein A, Koyfman S, Mardakh S, Yarmush JM, Schianodicola J. Pulseless electrical activity during electroconvulsive therapy: a case report. BMC Anesthesiol. 2012;12:8.
Kurnutala LN, Kamath S, Koyfman S, Yarmush J, SchianodiCola J. Aspiration during electroconvulsive therapy under general anesthesia. J ECT. 2013;29, e68.
Zibrak JD, Jensen WA, Bloomingdale K. Aspiration pneumonitis following electroconvulsive therapy in patients with gastroparesis. Biol Psychiatry. 1988;24:812–4.
Abrams R. Technique of electoconvulsive therapy: theory. In: Abrams R, editor. Electroconvulsive therapy. 4th ed. New York: Oxford University Press; 2002. p. 168.
Tecoult E, Nathan N. Morbidity in electroconvulsive therapy. Eur J Anaesthesiol. 2001;18:511–8.
Swartz CM. Electroconvulsive therapy emergence agitation and succinylcholine dose. J Nerv Ment Dis. 1990;178:455–7.
Meignan ML. Morbidity in electroconvulsive therapy. Eur J Anaesthesiol. 2002;19:614–5; author reply 5.
Wild B, Eschweiler GW, Bartels M. Morbidity in electroconvulsive therapy. Eur J Anaesthesiol. 2002;19:616.
Hasler WL. Gastroparesis. Curr Opin Gastroenterol. 2012;28:621–8.
American Society of Anesthesiologists Committee. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology. 2011;114:495–511.
Hagberg CA, Artime CA. Airway mangement in the adult. In: Miller RD, editor. Miller’s anesthesia, vol. 1. 8th ed. Philadelphia: Elsevier Saunders; 2015. p. 1647–83.
Smith I, Kranke P, Murat I, Smith A, O’Sullivan G, Soreide E, Spies C, in’t Veld B. Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2011;28:556–69.
Berrios GE, Sage G. Patients who break their fast before ECT. Br J Psychiatry. 1986;149:294–5.
Buisseret P. Acute pulmonary oedema following grand mal epilepsy and as a complication of electric shock therapy. Br J Dis Chest. 1982;76:194–5.
Cochran M, DeBattista C, Schmiesing C, Brock-Utne JG. Negative-pressure pulmonary edema: a potential hazard in patients undergoing ECT. J ECT. 1999;15:168–70.
Hatta K, Kitajima A, Ito M, Usui C, Arai H. Pulmonary edema after electroconvulsive therapy in a patient treated for long-standing asthma with a β2 stimulant. J ECT. 2007;23:26–7.
Myers CL, Gopalka A, Glick D, Goldman MB, Dinwiddie SH. A case of negative-pressure pulmonary edema after electroconvulsive therapy. J ECT. 2007;23:281–3.
Ring BS, Parnass SM, Shulman RB, Phelan J, Khan SA. Cardiogenic shock after electroconvulsive therapy. Anesthesiology. 1996;84:1511–3.
Wayne SL, O'Donovan CA, McCall WV, Link K. Postictal neurogenic pulmonary edema: experience from an ECT model. Convuls Ther. 1997;13:181–4.
Tsutsumi N, Tohdoh Y, Kawana S, Kozuka Y, Namiki A. A case of pulmonary edema after electroconvulsive therapy under propofol anesthesia. Masui. 2001;50:525–7.
Price JW, Price JR, Perry TL. Excessive hypertension and pulmonary edema after electroconvulsive therapy. J ECT. 2005;21:174–7.
Graham Jr JM, Tackels D, Dibbern K, Superneau D, Rogers C, Corning K, Schwartz CE. FG syndrome: report of three new families with linkage to Xq12-q22.1. Am J Med Genet. 1998;80:145–56.
Salmo EN, Connolly CE. Mortality in epilepsy in the west of Ireland: a 10-year review. Ir J Med Sci. 2002;171:199–201.
Reynolds RW. Pulmonary edema as a consequence of hypothalamic lesions in rats. Science. 1963;141:930–2.
Sarnoff SJ, Sarnoff LC. Neurohemodynamics of pulmonary edema. II. The role of sympathetic pathways in the elevation of pulmonary and stemic vascular pressures following the intracisternal injection of fibrin. Circulation. 1952;6:51–62.
Brashear RE, Pamintuan RL. Increased pulmonary diffusing capacity and elevated cerebrospinal fluid pressure. J Appl Physiol. 1971;30:844–6.
Sarnoff SJ, Berglund E. Neurohemodynamics of pulmonary edema. IV. Effect of systemic vasoconstriction and subsequent vasodilation on flow and pressures in systemic and pulmonary vascular beds. Am J Physiol. 1952;170:588–600.
Robin ED, Cross CE, Zelis R. Pulmonary edema. 1. N Engl J Med. 1973;288:239–46.
Gandhi SK, Powers JC, Nomeir AM, Fowle K, Kitzman DW, Rankin KM, Little WC. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med. 2001;344:17–22.
Fawver J, Milstein V. Asthma/emphysema complication of electroconvulsive therapy: a case study. Convuls Ther. 1985;1:61–4.
Kurup V. Respiratory diseases. In: Hines RL, Marschall KE, editors. Stoelting’s ansthesia and co-existing disease. 5th ed. Philadelphia: Saunders Elsevier; 2008. p. 161–97.
National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007;120:S94–138.
Lougheed MD, Leniere C, Ducharme FM, Licskai C, Dell SD, Rowe BH, FitzGerald M, Leigh R, Watson W, Boulet LP. Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults: executive summary. Can Respir J. 2012;19:e81–8.
Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–65.
Nagele P, Hüpfl M. Anesthesia and prehospital emergency and trauma care. In: Miller RD, editor. Miller’s anesthesia, vol. 2. 8th ed. Philadelphia: Elsevier Saunders; 2015. p. 2460–78.
Krystal AD. Managing the ECT seizure. In: Mankad MV, Beyer JL, Weiner RD, Krystal AD, editors. Clinical manual of electroconvulsive therapy. Arlington: American Psychiatric Publishing, Inc.; 2010. p. 149–57.
Weiner RD, Coffey CE, Krystal AD. The monitoring and management of electrically induced seizures. Psychiatr Clin North Am. 1991;14:845–69.
American Psychiatric Association. The practice of electroconvulsive therapy: recommendations for treatment, training, and priveleging, A task force report of the American Psychiatric Association. 2nd ed. Washington, DC: American Psychiatric Association; 2001. p. 193–4.
Walter G, Rey JM. An epidemiological study of the use of ECT in adolescents. J Am Acad Child Adolesc Psychiatry. 1997;36:809–15.
American Psychiatric Association, editor. The practice of electroconvulsive therapy: recommendations for treatment, training, and priveleging, A task force report of the American Psychiatric Association. 2nd ed. Washington, DC: American Psychiatric Association; 2001. p. 77–95.
Saito S, Miyoshi S, Yoshikawa D, Shimada H, Morita T, Kitani Y. Regional cerebral oxygen saturation during electroconvulsive therapy: monitoring by near-infrared spectrophotometry. Anesth Analg. 1996;83:726–30.
Pansare NH, Trenton AJ, Pelchat R. Electroconvulsive therapy performed 6 days after repair of an intracranial aneurysm using a liquid embolic system. J ECT. 2014;30:e19–21.
Maltbie AA, Wingfield MS, Volow MR, Weiner RD, Sullivan JL, Cavenar Jr JO. Electroconvulsive therapy in the presence of brain tumor. Case reports and an evaluation of risk. J Nerv Ment Dis. 1980;168:400–5.
Rasmussen KG, Perry CL, Sutor B, Moore KM. ECT in patients with intracranial masses. J Neuropsychiatry Clin Neurosci. 2007;19:191–3.
Patkar AA, Hill KP, Weinstein SP, Schwartz SL. ECT in the presence of brain tumor and increased intracranial pressure: evaluation and reduction of risk. J ECT. 2000;16:189–97.
Kramer BA. Use of ECT in California, 1977–1983. Am J Psychiatry. 1985;142:1190–2.
Najjar F, Guttmacher LB. ECT in the presence of intracranial aneurysm. J ECT. 1998;14:266–71.
Martin M, Figiel G, Mattingly G, Zorumski CF, Jarvis MR. ECT-induced interictal delirium in patients with a history of a CVA. J Geriatr Psychiatry Neurol. 1992;5:149–55.
Selim M. Perioperative stroke. N Engl J Med. 2007;356:706–13.
Awasthy N, Chand K. Subdural hematoma – a complication of electro convulsive therapy. Pak J Med Sci. 2005;21:491–3.
Saha D, Bisui B, Thakurta RG, Ghoshmaulik S, Singh OP. Chronic subdural hematoma following electro convulsive therapy. Indian J Psychol Med. 2012;34:181–3.
Kulkarni RR, Melkundi S. Subdural hematoma: an adverse event of electroconvulsive therapy-case report and literature review. Case Rep Psychiatry. 2012;2012:585303.
Dinwiddie SH, Huo D, Gottlieb O. The course of myalgia and headache after electroconvulsive therapy. J ECT. 2010;26:116–20.
Kertesz DP, Trabekin O, Vanetik MS. Headache treatment after electroconvulsive treatment: a single-blinded trial comparator between Eletriptan and Paracetamol. J ECT. 2015;31:105–9.
Leung M, Hollander Y, Brown GR. Pretreatment with ibuprofen to prevent electroconvulsive therapy-induced headache. J Clin Psychiatry. 2003;64:551–3.
Markowitz JS, Kellner CH, DeVane CL, Beale MD, Folk J, Burns C, Liston HL. Intranasal sumatriptan in post-ECT headache: results of an open-label trial. J ECT. 2001;17:280–3.
Kellner CH, Bryson EO. Electroconvulsive therapy anesthesia technique: minimalist versus maximally managed. J ECT. 2013;29:153–5.
DeBattista C, Mueller K. Sumatriptan prophylaxis for postelectroconvulsive therapy headaches. Headache. 1995;35:502–3.
Yatham LN, Liddle PF, Lam RW, Zis AP, Stoessl AJ, Sossi V, Adam MJ, Ruth TJ. Effect of electroconvulsive therapy on brain 5-HT2 receptors in major depression. Br J Psychiatry. 2010;196:474–9.
Mirzakhani H, Welch CA, Eikermann M, Nozari A. Neuromuscular blocking agents for electroconvulsive therapy: a systematic review. Acta Anaesthesiol Scand. 2012;56:3–16.
Murphy GS, De Boer HD, Eriksson LI, Miller RD. Reversal (antagonism) of neuromuscular blockade. In: Miller RD, editor. Miller’s anesthesia, vol. 1. 8th ed. Philadelphia: Elsevier Saunders; 2015. p. 995–1027.
Jain M, Arya A, Jha DK, Mehrotra S, Sarma U, Mehra A. Aggravated spinal cord compression following electroconvulsive therapy. J Anaesthesiol Clin Pharmacol. 2010;26:572.
Briggs MC, Popeo DM, Pasculli RM, Bryson EO, Kellner CH. Safe resumption of electroconvulsive therapy (ECT) after vertebroplasty. Int J Geriatr Psychiatry. 2012;27:984–5.
Kellner CH, Tolhurst JE, Burns CM. ECT in the presence of severe cervical spine disease. Convuls Ther. 1991;7:52–5.
O'Connell RA. A review of the use of electroconvulsive therapy. Hosp Community Psychiatry. 1982;33:469–73.
Shaheen MA, Sabet NA. Bilateral simultaneous fracture of the femoral neck following electrical shock. Injury. 1984;16:13–4.
Nott MR, Watts JS. A fractured hip during electro-convulsive therapy. Eur J Anaesthesiol. 1999;16:265–7.
Browne AO, Sheehan JM. Bilateral central dislocation of the hip: a case report. Orthop Rev. 1986;15:733–5.
Ribbans WJ. Bilateral anterior dislocation of the shoulder following a grand-mal convulsion. Br J Clin Pract. 1989;43:181–2.
Rodia F, Ventura A, Touloupakis G, Theodorakis E, Ceretti M. Missed posterior shoulder dislocation and McLaughlin lesion after an electrocution accident. Chin J Traumatol. 2012;15:376–8.
Rawat S, Meena S, Gangari SK, Lohia LK. Anterior dislocation of shoulder in eclampsia: a case report. Chin J Traumatol. 2012;15:249–50.
Auriacombe M, Reneric JP, Usandizaga D, Gomez F, Combourieu I, Tignol J. Post-ECT agitation and plasma lactate concentrations. J ECT. 2000;16:263–7.
Fink M. Post-ECT Delirium. Convuls Ther. 1993;9:326–30.
Augoustides JG, Greenblatt E, Abbas MA, O'Reardon JP, Datto CJ. Clinical approach to agitation after electroconvulsive therapy: a case report and literature review. J ECT. 2002;18:213–7.
Cohen MB, Stewart JT. Treatment of post-electroconvulsive therapy agitation with dexmedetomidine. J ECT. 2013;29:e23–4.
Aneja J, Grover S, Agarwal M, Kaushik S. Use of electroconvulsive therapy in the presence of glaucoma: a case report and review of literature. Indian J Psychol Med. 2013;35:80–3.
Good MS, Dolenc TJ, Rasmussen KG. Electroconvulsive therapy in a patient with glaucoma. J ECT. 2004;20:48–9.
Boroojeny SB, Tabatabai NH, Babakhani B, Babakhani S, Moody Z. The effect of electroconvulsive therapy using propofol and succinylcholine on the intraocular pressure. Middle East J Anesthesiol. 2012;21:713–7.
Sibony PA. ECT risks in glaucoma. Convuls Ther. 1985;1:283–5.
American Psychiatric Association. The practice of electroconvulsive therapy: recommendations for treatment, training, and priveleging, A task force report of the American Psychiatric Association. 2nd ed. Washington, DC: American Psychiatric Association; 2001. p. 41–2.
Waters DJ, Mapleson WW. Suxamethonium pains: hypothesis and observation. Anaesthesia. 1971;26:127–41.
McLoughlin C, Elliott P, McCarthy G, Mirakhur RK. Muscle pains and biochemical changes following suxamethonium administration after six pretreatment regimens. Anaesthesia. 1992;47:202–6.
Rasmussen KG, Petersen KN, Sticka JL, Wieme LJ, Zosel JH, Marienau ME, Ryan DA, Schroeder DR, Stevens SR, Hooten WM, Spackman TN. Correlates of myalgia in electroconvulsive therapy. J ECT. 2008;24:84–7.
Morris AJ, Roche SA, Bentham P, Wright J. A dental risk management protocol for electroconvulsive therapy. J ECT. 2002;18:84–9.
Kiran S, Bala R, Singh T. Dental protection during modified electroconvulsive therapy using roll-gauze mouth gag. J ECT. 2009;25:74–5.
McClure RE. A device for preventing dental injuries during ECT. Hosp Commun Psychiatry. 1969;20:357–9.
McCall WV, Minneman SA, Minneman SA, Weiner RD, Shelp FE, Austin S. Dental pathology in ECT patients prior to treatment. Convuls Ther. 1992;8:19–24.
American Psychiatric Association. The practice of electroconvulsive therapy: recommendations for treatment, training, and priveleging, A task force report of the American Psychiatric Association. 2nd ed. Washington, DC: American Psychiatric Association; 2001. p. 64–5.
Li TC, Shiah IS, Sun CJ, Tzang RF, Huang KC, Lee WK. Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature. J ECT. 2011;27:165–7.
Kramer BA. Anticholinergics and ECT. Convuls Ther. 1993;9:293–300.
Kellner CH, Li D, Maron L. Anesthesia for electroconvulsive therapy. In: Swartz CM, editor. Electroconvulsive and neuromodulation therapies. New York: Cambridge University Press; 2009. p. 414–5.
Greenan J, Dewar M, Jones CJ. Intravenous glycopyrrolate and atropine at induction of anaesthesia: a comparison. J R Soc Med. 1983;76:369–71.
Manjunatha N, Ram Kumar GS, Vidyendaran R, Muralidharan K, John JP. Delayed onset, protracted delirium and aspiration pneumonitis associated with a combination of clozapine and electroconvulsive therapy. Indian J Psychol Med. 2011;33:80–2.
Reddy S, Nobler MS. Dangerous hyperglycemia associated with electroconvulsive therapy. Convuls Ther. 1996;12:99–103.
Shimabukuro D, Liu LL. Cardiopulmonary resuscitation. In: Miller RD, Pardo Jr MC, editors. Basics of anesthesia. 6th ed. Philadelphia: Elsevier Saunders; 2011. p. 727.
Vervloet D, Magnan A, Birnbaum J, Pradal M. Allergic emergencies seen in surgical suites. Clin Rev Allergy Immunol. 1999;17:459–67.
Laxenaire MC. Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey (July 1994-December 1996). Ann Fr Anesth Reanim. 1999;18:796–809.
Hepner DL, Castells MC. Anaphylaxis during the perioperative period. Anesth Analg. 2003;97:1381–95.
Ebo DG, Fisher MM, Hagendorens MM, Bridts CH, Stevens WJ. Anaphylaxis during anaesthesia: diagnostic approach. Allergy. 2007;62:471–87.
Fisher MM, Baldo BA. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim. 1993;12:97–104.
Fasting S, Gisvold SE. Serious intraoperative problems–a five-year review of 83,844 anesthetics. Can J Anaesth. 2002;49:545–53.
Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999–2000. Anesthesiology. 2003;99:536–45.
Sadleir PH, Clarke RC, Bunning DL, Platt PR. Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011. Br J Anaesth. 2013;110:981–7.
Reddy JI, Cooke PJ, van Schalkwyk JM, Hannam JA, Fitzharris P, Mitchell SJ. Anaphylaxis is more common with rocuronium and succinylcholine than with atracurium. Anesthesiology. 2015;122:39–45.
Currie M, Webb RK, Williamson JA, Russell WJ, Mackay P, The Australian Incident Monitoring Study. Clinical anaphylaxis: an analysis of 2000 incident reports. Anaesth Intensive Care. 1993;21:621–5.
Mertes PM, Aimone-Gastin I, Gueant-Rodriguez RM, Mouton-Faivre C, Audibert G, O'Brien J, Frendt D, Brezeanu M, Bouaziz H, Gueant JL. Hypersensitivity reactions to neuromuscular blocking agents. Curr Pharm Des. 2008;14:2809–25.
Mitsuhata H, Matsumoto S, Hasegawa J. The epidemiology and clinical features of anaphylactic and anaphylactoid reactions in the perioperative period in Japan. Masui. 1992;41:1664–9.
Axon AD, Hunter JM. Editorial III: Anaphylaxis and anaesthesia–all clear now? Br J Anaesth. 2004;93:501–4.
Misra UK, Kalita J, Vajpeyee A, Mandhani A, Sharma RK. Bladder rupture: a rare complication of tonic-clonic seizures. QJM. 2003;96:542–3.
Irving AD, Drayson AM. Bladder rupture during ECT. Br J Psychiatry. 1984;144:670.
O'Brien PD, Morgan DH. Bladder rupture during ECT. Convuls Ther. 1991;7:56–9.
Abrams R. Technique of electoconvulsive therapy: theory. In: Abrams R, editor. Electroconvulsive therapy. 4th ed. New York: Oxford University Press; 2002. p. 168–9.
van Schaik AM, Klumpers UM, de Gast HM, Kubbe DA, Stek ML. Gastric rupture after electroconvulsive therapy. J ECT. 2006;22:153–4.
Devanand DP, Prudic J, Sackeim HA. Electroconvulsive therapy-induced hypomania is uncommon. Convuls Ther. 1992;8:296–8.
American Psychiatric Association. The practice of electroconvulsive therapy: recommendations for treatment, training, and priveleging, A task force report of the American Psychiatric Association. 2nd ed. Washington, DC: American Psychiatric Association; 2001. p. 66–73.
UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361:799–808.
Sackeim HA, Prudic J, Fuller R, Keilp J, Lavori PW, Olfson M. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology. 2007;32:244–54.
Rose D, Fleischmann P, Wykes T, Leese M, Bindman J. Patients’ perspectives on electroconvulsive therapy: systematic review. BMJ. 2003;326:1363.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Japan
About this chapter
Cite this chapter
Wajima, Z. (2016). Complication of Electroconvulsive Therapy. In: Saito, S. (eds) Anesthesia Management for Electroconvulsive Therapy. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55717-3_7
Download citation
DOI: https://doi.org/10.1007/978-4-431-55717-3_7
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55716-6
Online ISBN: 978-4-431-55717-3
eBook Packages: MedicineMedicine (R0)